Search Results - "Cool, Rita"

NCCN Guidelines Insights: Hematopoietic Growth Factors, Version 1.2020 by Becker, Pamela Sue, Griffiths, Elizabeth A, Alwan, Laura M, Bachiashvili, Kimo, Brown, Anna, Cool, Rita, Curtin, Peter, Dinner, Shira, Gojo, Ivana, Hicks, Ashley, Kallam, Avyakta, Kidwai, Wajih Zaheer, Kloth, Dwight D, Kraut, Eric H, Landsburg, Daniel, Lyman, Gary H, Miller, Ryan, Mukherjee, Sudipto, Patel, Shiven, Perez, Lia E, Poust, Adam, Rampal, Raajit, Rosovsky, Rachel, Roy, Vivek, Rugo, Hope S, Shayani, Sepideh, Vasu, Sumithira, Wadleigh, Martha, Westbrook, Kelly, Westervelt, Peter, Burns, Jennifer, Keller, Jennifer, Pluchino, Lenora A

“…Management of febrile neutropenia (FN) is an integral part of supportive care for patients undergoing cancer treatment. The NCCN Guidelines for Hematopoietic…”
Get more information

Rhabdomyolysis After Concomitant Use of Simvastatin and Voriconazole in an Allogeneic Stem Cell Transplant Patient by COOL, Rita M, GULBIS, Alison M

Get full text

Recurrent Peripheral Arterial Thrombosis Induced by Cisplatin and Etoposide by Cool, Rita M., Herrington, Jon D., Wong, Lucas

“…A 64–year‐old woman receiving intravenous chemotherapy for stage IIIB non‐small cell lung cancer experienced acute arterial thrombosis of the distal radial and…”
Get full text

West Nile Encephalitis in 2 Hematopoietic Stem Cell Transplant Recipients: Case Series and Literature Review by Hong, David S., Jacobson, Kalen L., Raad, Issam I., de Lima, Marcos, Anderlini, Paolo, Fuller, Gregory N., Ippoliti, Cindy, Cool, Rita M., Leeds, Norman E., Narvios, Aida, Han, Xiang Y., Padula, Anthony, Champlin, Richard E., Hosing, Chitra

“…Most human cases of West Nile virus infection are acquired via bites from an infected mosquito. In some cases, infection may also be transmitted by infected…”
Get full text

Thalidomide for the Treatment of Relapsed and Refractory Multiple Myeloma by Cool, Rita M., Herrington, Jon D.

“…Thalidomide is the first drug in over 20 years to demonstrate clinically significant activity in patients with multiple myeloma. Although the survival rate has…”
Get full text

A randomized phase III study of pretransplant conditioning for AML/MDS with fludarabine and once daily IV busulfan ± clofarabine in allogeneic stem cell transplantation by Andersson, Borje S., Thall, Peter F., Ma, Junsheng, Valdez, Benigno C., Bassett, Roland, Chen, Julianne, Ahmed, Sairah, Alousi, Amin, Bashir, Qaiser, Ciurea, Stefan, Gulbis, Alison, Cool, Rita, Kawedia, Jitesh, Hosing, Chitra, Kebriaei, Partow, Kornblau, Steve, Myers, Alan, Oran, Betul, Rezvani, Katayoun, Shah, Nina, Shpall, Elizabeth, Parmar, Simrit, Popat, Uday R., Nieto, Yago, Champlin, Richard E.

“…Pretransplant conditioning with Fludarabine (Flu)-Busulfan (Bu) is safe, but clofarabine (Clo) has improved antileukemic activity. Hypothesis: Flu+Clo-Bu (FCB)…”
Get full text

Leukemia cell mobilization with G-CSF plus plerixafor during busulfan–fludarabine conditioning for allogeneic stem cell transplantation by Konopleva, M, Benton, C B, Thall, P F, Zeng, Z, Shpall, E, Ciurea, S, Kebriaei, P, Alousi, A, Popat, U, Anderlini, P, Nieto, Y, Parmar, S, Qiao, W, Chen, J, Rondon, G, McMullin, B, Wang, R-Y, Lu, H, Schober, W, Woodworth, G, Gulbis, A, Cool, R, Andreeff, M, Champlin, R

“…We hypothesized that during conditioning chemotherapy for allogeneic stem cell transplant (allo-SCT), the disruption of stromal–leukemia interactions using…”
Get full text

38 - Safety and Efficacy of a New High-Dose Chemotherapy (HDC) Regimen of Panobinostat (Pano), Gemcitabine (Gem), Busulfan (Bu) and Melphalan (Mel) (Pano/GBM) with Autologous Stem Cell Transplant (ASCT) for Patients (pts) with High-Risk (HR) or Refractory/Relapsed (R/R) Myeloma (MM) – Matched Pair Comparisons with a Concurrent Control Cohort by Nieto, Yago, Yang, Zixi, Valdez, Ben C., Kundu, Suprateek, Bassett, Roland, Barnett, Melissa, Bashir, Qaiser, Ramdial, Jeremy, Saini, Neeraj Y., Srour, Samer A., Im, Jin Seon, Kebriaei, Partow, Popat, Uday R., Gulbis, Alison M., Cool, Rita, Shigle, Terri Lynn, Wallis, Whitney Dale, Yeh, Jason, Delgado, Ruby, Qureshi, Sofia, Lee, Hans C., Manasanch, Elisabet, Orlowski, Robert Z., Thomas, Sheeba K., Shpall, Elizabeth J., Andersson, Borje S., Qazilbash, Muzaffar H.

Get full text

Safety and Efficacy of a New High-Dose Chemotherapy (HDC) Regimen of Panobinostat (Pano), Gemcitabine (Gem), Busulfan (Bu) and Melphalan (Mel) (Pano/GBM) with Autologous Stem Cell Transplant (ASCT) for Patients (pts) with High-Risk (HR) or Refractory/Relapsed (R/R) Myeloma (MM) – Matched Pair Comparisons with a Concurrent Control Cohort by Nieto, Yago, Yang, Zixi, Valdez, Ben C., Kundu, Suprateek, Bassett, Roland, Barnett, Melissa, Bashir, Qaiser, Ramdial, Jeremy, Saini, Neeraj Y., Srour, Samer A., Im, Jin Seon, Kebriaei, Partow, Popat, Uday R., Gulbis, Alison M., Cool, Rita, Shigle, Terri Lynn, Wallis, Whitney Dale, Yeh, Jason, Delgado, Ruby, Qureshi, Sofia, Lee, Hans C., Manasanch, Elisabet, Orlowski, Robert Z., Thomas, Sheeba K., Shpall, Elizabeth J., Andersson, Borje S., Qazilbash, Muzaffar H.

Get full text

NCCN Guidelines® Insights: Hematopoietic Growth Factors, Version 1.2022 by Griffiths, Elizabeth A, Roy, Vivek, Alwan, Laura, Bachiashvili, Kimo, Baird, John, Cool, Rita, Dinner, Shira, Geyer, Mark, Glaspy, John, Gojo, Ivana, Hicks, Ashley, Kallam, Avyakta, Kidwai, Wajih Zaheer, Kloth, Dwight D, Kraut, Eric H, Landsburg, Daniel, Lyman, Gary H, Mahajan, Anjlee, Miller, Ryan, Nachar, Victoria, Patel, Seema, Patel, Shiven, Perez, Lia E, Poust, Adam, Riaz, Fauzia, Rosovsky, Rachel, Rugo, Hope S, Simon, Shayna, Vasu, Sumithira, Wadleigh, Martha, Westbrook, Kelly, Westervelt, Peter, Berardi, Ryan A, Pluchino, Lenora

“…The NCCN Guidelines for Hematopoietic Growth Factors provide recommendations for the appropriate use of growth factors in the clinical management of febrile…”
Get more information

The impact of pre-transplant valganciclovir on early cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation by Wilhelm, Kaci, Chemaly, Roy, Saliba, Rima, Gulbis, Alison, Saunders, Ila, Cool, Rita, Ferguson, Jill, Westmoreland, Michael, Rondon, Gabriela, Kebriaei, Partow

“…Cytomegalovirus reactivation is a common complication of allogeneic hematopoietic stem cell transplant. The use of pre-transplant valganciclovir during the…”
Get full text

Leukemia Cell Mobilization with Plerixafor Plus G-CSF with Busulfan/Fludarabine and Allogeneic Hematopoietic Cell Transplantation in Patients with AML/MDS Is Associated with Decreased Complete Chimerism and GvHD, and Increased Risk of Relapse by Benton, Christopher B., Konopleva, Marina, Saliba, Rima M, Shpall, Elizabeth J., Ciurea, Stefan O., Kebriaei, Partow, Alousi, Amin M., Popat, Uday R., Anderlini, Paolo, Nieto, Yago, Parmar, Simrit, Zeng, Zhihong, Chen, Julianne J, Rondon, Gabriela, McMullin, Becky, Wang, Rui-Yu, Lu, Hongbo, Schober, Wendy D., Woodworth, Glenda G, Gulbis, Alison, Cool, Rita, Qiao, Wei, Thall, Peter F, Andreeff, Michael, Champlin, Richard E.

“…Abstract ▪360▪This icon denotes a clinically relevant abstract The goal of preparative regimen in allogeneic stem cell transplant (allo-SCT) is to eradicate…”
Get full text

A Phase I/II Trial of Plerixafor/G-CSF Combined with IV Bu/Flu Conditioning Regimen In AML/MDS Patients Undergoing Allogenic Stem Cell Transplantation by Konopleva, Marina, Zhihong, Zeng, Wang, Rui-Yu, Thall, Peter F., McCormick, Gloria, Lu, Hongbo, Chen, Julianne J, Shpall, Elizabeth J., Ciurea, Stefan O., Kebriaei, Partow, Alousi, Amin M, Popat, Uday, Anderlini, Paolo, Nieto, Yago, Parmar, Simrit, McMullin, Becky, Rondon, Gabriela, Schober, Wendy D., Gulbis, Alison, Cool, Rita, Lin, E., Andreeff, Michael, Champlin, Richard

“…Abstract 2358 Allogeneic stem cell transplantation (alloSCT) is an effective treatment for pts with acute myeloid leukemia (AML) in first remission. However,…”
Get full text

Recurrent Peripheral Arterial Thrombosis Induced by Cisplatin and Etoposide by Cool, Rita M., Herrington, Jon D., Wong, Lucas

Get full text